Article Information
History
- March 25, 2021.
Article Versions
- Version 1 (September 14, 2020 - 05:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Benjamin Hur1,2,
- Vinod K. Gupta1,2,
- Harvey Huang3,
- Kerry A. Wright4,
- Kenneth J. Warrington4,
- Veena Taneja5,
- John M. Davis III4,* and
- Jaeyun Sung1,2,4,*,†
- 1Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA
- 2Division of Surgery Research, Department of Surgery, Mayo Clinic, Rochester, MN, USA
- 3Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN, USA
- 4Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA
- 5Department of Immunology, Mayo Clinic, Rochester, MN, USA
- ↵†Corresponding author: Sung.Jaeyun{at}mayo.edu
↵* Contributed equally as co-senior authors
Posted March 25, 2021.
Plasma Metabolomic Profiling in Patients with Rheumatoid Arthritis Identifies Biochemical Features Predictive of Quantitative Disease Activity
